Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2300072732Phase 4Recruiting
Phase 4, open-label trial of ciprofol and propofol (3 arms), sponsored by The First Affiliated Hospital of Guangxi Medical University. Primary endpoint: Sedation success rate. Started Jun 2023; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2300072732.